Healthcare provider profile · identity verified

William Ryan Jones, MD

Family Practice · AUSTIN, TX · NPI 1205329471

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	268	102
Amlodipine Besylate	Amlodipine Besylate	138	54
Levothyroxine Sodium	Levothyroxine Sodium	138	46
Lisinopril	Lisinopril	117	44
Rosuvastatin Calcium	Rosuvastatin Calcium	115	43
Losartan Potassium	Losartan Potassium	113	40
Albuterol Sulfate Hfa	Albuterol Sulfate	99	41
Tamsulosin Hcl	Tamsulosin Hcl	97	38
Gabapentin	Gabapentin	88	35
Omeprazole	Omeprazole	74	34
Metoprolol Tartrate	Metoprolol Tartrate	70	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	14
Ibuprofen	Ibuprofen	63	21
Metformin Hcl	Metformin Hcl	62	23
Trazodone Hcl	Trazodone Hcl	61	27
Simvastatin	Simvastatin	57	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	19
Meloxicam	Meloxicam	53	34
Atenolol	Atenolol	49	18
Metformin Hcl Er	Metformin Hcl	46	22
Prednisone	Prednisone	45	36
Pradaxa	Dabigatran Etexilate Mesylate	44	15
Alendronate Sodium	Alendronate Sodium	42	15
Spiriva Respimat	Tiotropium Bromide	41	12
Glipizide	Glipizide	39	15
Sertraline Hcl	Sertraline Hcl	38	suppressed
Furosemide	Furosemide	37	17
Hydrochlorothiazide	Hydrochlorothiazide	35	13
Potassium Chloride	Potassium Chloride	35	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	34	suppressed
Alvesco	Ciclesonide	33	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	11
Pantoprazole Sodium	Pantoprazole Sodium	32	13
Triamcinolone Acetonide	Triamcinolone Acetonide	32	16
Metoprolol Succinate	Metoprolol Succinate	30	12
Wixela Inhub	Fluticasone Propion/Salmeterol	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Ozempic	Semaglutide	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Humulin N	Insulin Nph Human Isophane	24	suppressed
Allopurinol	Allopurinol	23	suppressed
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Cephalexin	Cephalexin	21	11
Propranolol Hcl	Propranolol Hcl	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Famotidine	Famotidine	19	suppressed
Finasteride	Finasteride	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	18
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	18	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Naproxen	Naproxen	15	suppressed
Azithromycin	Azithromycin	14	13
Chlorthalidone	Chlorthalidone	14	suppressed
Eliquis	Apixaban	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	13	13
Spironolactone	Spironolactone	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Primidone	Primidone	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error